alivus.comCrawled Nov 7, 2026
Alivus provides active pharmaceutical ingredients and contract development and manufacturing services for global pharmaceutical needs.
Alivus strengthens its business through service offerings across markets, positioning itself as a partner for pharmaceutical needs.
The section on Intimations to Stock Exchanges/Disclosures/Latest Announcements serves as a vital communication channel, ensuring timely and..
Intimations to Stock Exchanges/ Disclosures/ Latest Announcements Home / Investors / Corporate Governance INTIMATIONS TO STOCK EXCHANGES/DISCLOSURES/ LATEST ANNOUNCEMENTS FY 2025-26 Annual Disclosure to be made by an entity identified as a Large Corporate VIEW
Alivus Life Sciences Ltd prioritizes research, manufacturing, and supplying high-quality active pharmaceutical ingredients to improve lives.
Management Profiles Home / Media / Management Profiles Dr. Yasir Rawjee Dr. Yasir Rawjee × Managing Director and Chief Executive Officer Dr. Yasir Rawjee is the Managing Director and Chief Executive Officer of our Company. He leads the overall operations of our Company and is responsible for the overall business strategy of our Company. He holds […]
Alivus commits to minimizing its carbon and water footprint through environmental initiatives.
Alivus is a subsidiary of Nirma Limited, a diversified conglomerate with interests in consumer products, cement, and chemicals.
Alivus focuses on research and development to drive innovation in pharmaceutical chemistry.
Alivus aims to contribute to patient health and collaborate with partners to improve lives globally.
Alivus Life Sciences is a leading developer and manufacturer of select high value, non-commoditized Active Pharmaceutical Ingredients (APIs)
